The major questions about reductions in the number of cigarettesday as a treatment goal are (1) 
Introduction
ª Reduced smokingº (reduction in the number of cigarettesday among continuing smokers) is one of several non-cessation ª harm reductionº approaches to smoking that have been discussed in the developed countries for several reasons. 1± 4 Although ª reduced smokingº has been used as a method to achieve cessation, 5 the present article focuses on reduced smoking as a goal itself among smokers unwilling to make a quit attempt. The most prominent reasons are: (a) traditional approaches to smoking are not working as indicated by a recent plateauing of prevalence rates and of quitting behavior in countries such as the US, 5 (b) traditional treatment targets only the 5± 20% of smokers interested in quitting immediately 7 and (c) although more treatments are available, cessation rates with recent treatments are not substantially greater. 8 With the exception of Denmark and Finland, countrieshave not approved promotion of reduced smoking.
This article examines the existing evidence on ® ve important questions about reduced smoking: (1) how many smokers can reduce their smoking and maintain this reduction, (2) how much compensation occurs, (3) will reduced smoking signi® cantly decrease the risk of smoking and (4) will reduction promote or undermine cessation. 13 
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2 8 6 reductions has been examined in three naturalistic populations: all smokers, smokers who have just relapsed after a quit attempt, and smokers not interested in quitting. Among all smokers, the only population-based studies that reported on reduction per se were the California Tobacco Surveys (CTS) and the Community Intervention Trial for Cessation (COMMIT). The CTSs were non-intervention surveys; however, several public health efforts to reduce smoking were ongoing at the time of the surveys. Between 1990 and 1991 many smokers in California spontaneously reduced smoking with a mean reduction of 48% among those who reduced. 9 One year later (1992), consumption in this group was still 43% of baseline ( Table 1) . The COMMIT trial was a multi-city public health intervention that focused on cessation and did not promote reduction itself. In COMMIT, 40% of smokers reduced and maintained their reduction for 3 years. 10 Among smokers trying to stop smoking, four studies found that many who relapse return to a lower level of smoking and maintain some amount of reduced smoking 6± 40 months post-cessation 11± 16 (Table 1) . Greater reductions appeared to occur in smokers in gradual cessation treatments than in those with abrupt cessation treatments. In the three studies with long-term follow-ups, 11, 12, 14 the amount of reduction dissipated over time in two of the studies.
Perhaps the most important population for smoking reduction is smokers who are not willing to try to stop smoking. Six studies have experimentally induced reduction in this population using either behavior therapy and/or nicotine replacement ( Table 2 ). The studies produced large reductions in cigarettes/day (median 5 42%). 17± 23 In the four studies with longterm follow-up, 17, 18, 20, 22 the mean reduction maintained was 24%, 15%, 30% and 54% at 6, 6, 6 and 20-month follow-ups.
In summary, many smokers are able to reduce their smoking spontaneously and maintain signi® cant reductions for long periods. In addition, behavior therapy and nicotine replacement appear to induce reduction.
How much compensation occurs?
In the studies of smokers not trying to stop, reductions in carbon monoxide (a marker of toxin exposure) were usually about 75% of reductions in self-reported cigarettes/day, indicating that some compensation occurred (Table 2) . Nevertheless, the reductions in carbon monoxide were still substantial (median 5 27%). In fact, if decreases in tobacco-related diseases are the major endpoint, then reductions in CO might be the primary outcome measure as it appears to be more related to toxin exposure and disease than self-reported cigarettes/day. 24 On the other hand, the one naturalistic study of relapsers that reported on compensation was the MRFIT trial.
14 This study reported no reduction in thiocyanate (a biochemical marker of smoking) despite a self-reported reduction of 26%. The one study of cotinine (a nicotine metabolite) was a study in which subjects used nicotine replacement to help them reduce smoking; thus, in this setting, cotinine cannot be used as a marker of tobacco toxins only. 25 Several other measures of toxin exposure have been suggested for studies of reduced smoking but all of these have signi® cant problems in sensitivity, speci® city or reliability. 25 In summary, most of the evidence indicates that some compensation occurs, but signi® cant reductions in toxins still remain.
Will reduced smoking decrease the risk of smoking-related diseases?
One major rationale for reduced smoking is that smoking-related morbidity and mortality are highly dose-related to the amount of smoking. 1 Although it makes sense that reducing cigarettes/ day would reduce risk, this has never been tested directly. There are two schools of thought about whether such a test is necessary.
One school would point out that the dose± response curve was derived from a cross-sectional association of the incidence/prevalence of disorders in people who self-selected into smoking groups. Most studies of dose± responsivity used post-hoc corrections for variables associated with smoking that might falsely in¯ate morbidity and mortality (e.g. alcohol use) among heavy smokers; however, such corrections are seldom complete. Thus, this school would argue that the decline in risk from reducing smoking may be substantially less than one would predict from the cross-sectional data. This school would also point out that the expected reductions in risk from low-tar cigarettes assumed from cross-sectional data have either not been found or found to be substantially less than would have been predicted.
26
The other school of thought would state that if one believes that smoking causes morbidity and mortality in a dose-related manner (as almost everyone does) then, logically, it must follow that reducing smoking reduces risk. They would agree that the amount of risk reduction might not be quanti® able, but they would also point out that a study to demonstrate risk reduction with reduced smoking would require thousands of subjects and take at least 8 years from inception to results. This school would state that the harm from smoking is very prevalent and of large magnitude, that the risk of reduced smoking is very low and the bene® ts of reduction are so face-valid that we cannot wait 8 years and condemn thousands of smokers to die while waiting for a de® nitive study.
A compromise solution would be to ® nd a disease marker that could serve as proxy for morbidity and mortality (lipid levels, mutagenesis assays, etc.). Unfortunately, although several markers are available, none has suf® cient sensitivity and speci® city to act as a good proxy.
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Does reduced smoking undermine or promote smoking cessation? Reducing one's consumption of cigarettes/day could be thought to increase self-ef® cacy, decrease nicotine dependency and thus make cessation more likely. On the other hand, one other method of harm reduction, switching to low-tar/ low-nicotine cigarettes, has been associated with lower, not greater, rates of cessation, 27 as if smokers had used switching to low-tar cigarettes as an alternative to cessation. The two general population studies 9, 10 and one relapse study 11 followed subjects after they had reduced their smoking (Table 3) . In all three studies the rates of smoking cessation attempts or cessation itself was increased among the small group who reduced more than 50%. However, little or no increase in cessation was seen with the much more prevalent smaller amounts of reduction (i.e. 5± 50%). 9, 10, 11 Among the experimental trials of reduction, two reported increased motivation for cessation after participating in the trial; 19, 23 however, neither had a control group to determine if this was due to reduced smoking per se. In summary, there is no evidence thus far that reduction undermines cessation. Whether reduction increases cessation is unclear.
Importantly, the evidence on cessation reviewed above only focuses on those interested in reducing. We know of no tests of whether advocating reduction to an entire population would produce a net increase or decrease in cessation or initiation.
Conclusion
Many smokers not interested in quitting and many smokers who have just relapsed appear able to reduce their smoking signi® cantly and maintain this for substantial periods of time. Although some compensation occurs, toxin levels are usually still substantially reduced. Whether reduced smoking can reduce risk has not been tested and whether such a test is necessary is debatable. Reducing smoking does not appear to undermine cessation and may increase motivation for cessation. We still need a large controlled experimental trial of smoking reduction which follows subjects for long periods with biochemical measures of toxins and which measures future cessation attempts and successes.
